Search Results (415)

Hypertension is the most common comorbidity in chronic kidney disease (CKD), affecting roughly 80–85% of patients overall and an even higher proportion in nondialysis CKD G3–G5. This narrative review examines whether, and under what clinical conditions, fruits, vegetables, and legumes can be used safely in adults with hypertensive CKD, especially nondialysis CKD G3–G5, as well as moderate to severe loss of kidney function, paying close attention to the gut microbiota, short-chain fatty acids, gut-derived uremic toxins, potassium bioavailability, and modifiable clinical risk factors. The clinical effect of plant foods on serum potassium cannot be predicted from total potassium content alone. The Kidney Disease: Improving Global Outcomes (KDIGO) 2024 guidelines explicitly advise individualized potassium management and emphasize limiting foods rich in bioavailable potassium, especially processed foods, rather than reflexively restricting fruits and vegetables. Across CKD studies, the association between dietary potassium and serum potassium is weak or inconsistent, and the risk of hyperkalemia is modified by kidney function, bowel function, metabolic acidosis, diabetes and hyperglycemia, medications, food processing, and the food matrix itself. Potassium bioavailability varies substantially according to the food matrix, preparation method, portion size, and processing method; some minimally processed plant foods may provide less readily absorbable potassium than potassium-rich processed foods, juices, or potassium additives. Fruits, vegetables, and legumes also provide fiber, resistant starch, and polyphenols that can support saccharolytic fermentation, short-chain fatty acid production, bowel transit, and lower concentrations of some gut-derived uremic toxins. However, blood-pressure and kidney-outcome benefits in CKD are supported more strongly by observational and selected alkali-diet trials than by large microbiome-focused randomized studies. In hypertensive CKD, fruits, vegetables, and legumes should not be universally restricted simply because they contain potassium. A safer and more evidence-aligned strategy is individualized, food-source-aware prescribing that prioritizes minimally processed plant foods, accounts for preparation method and portion size, corrects constipation and acidosis, reviews potassium-raising medications and additives, and monitors serum potassium according to baseline risk. Full article

Stearidonic acid (SDA) and γ-linolenic acid (GLA) are recognized for their anti-inflammatory and cardiometabolic benefits, yet their natural dietary sources remain scarce. This study aimed to develop and optimize the enzymatic synthesis of lysophosphatidylcholine (LPC) enriched with GLA and SDA in a solvent-free system using Echium plantagineum seed oil as the source of GLA and SDA. Enzyme screening was conducted with three immobilized lipases, among which Lipozyme^® 435 exhibited superior performance, achieving significantly higher proportions of both GLA and SDA into the LPC backbone compared with alternative lipases. Reaction optimization was performed using a Box–Behnken response surface design, evaluating temperature, time, lipase load, and substrate molar ratio. The analysis identified lipase load as the most influential factor for both fatty acid proportion and LPC yield. At 50 °C for 24 h, with a substrate molar ratio of 1:15 and a 15 wt% lipase load, the synthesis yielded 92.0 ± 4.1 mol%. Within the LPC fraction, GLA + SDA contributed 69.5 ± 1.2% of total fatty acids. The resulting structured LPC combines the enhanced bioavailability of the lysophospholipid carrier with the complementary metabolic activities of GLA and SDA, supporting its potential for the development of functional foods and nutraceutical formulations. Full article

Background/Objectives: Obesity is paradoxically associated with iron deficiency despite adequate dietary intake, driven by chronic inflammation and elevated hepcidin. Different dietary patterns may differentially affect iron metabolism in obese individuals, yet comparative evidence remains limited. Methods: We conducted a systematic literature review following PRISMA 2020 guidelines. Four databases (SciSpace, Google Scholar, PubMed) were searched through 2025 using terms related to obesity, iron deficiency, and three dietary patterns: Mediterranean diet, ketogenic diet, and intermittent fasting. Studies were screened using seven predefined criteria (three inclusion, four exclusion) with thresholds of ≥4.0/5.0 for abstract screening and ≥4.5/5.0 for full-text screening. Results: From 396 identified records (SciSpace n = 325, Google Scholar n = 57, PubMed n = 14), 38 studies were included after removing 62 duplicates and screening 334 unique records. Studies without accessible full text were excluded.The Mediterranean diet appears most protective for iron status due to its anti-inflammatory profile (omega-3 fatty acids, polyphenols, vitamin C) and bioavailable iron sources. Ketogenic diets may impair duodenal iron absorption through hepcidin-independent mechanisms and restrict dietary iron diversity. Intermittent fasting shows complex effects, remodeling iron metabolism with increased transferrin and decreased ferritin within physiological ranges. Weight loss per se consistently improves iron status by reducing adipose-driven inflammation and lowering hepcidin. Conclusions: Among the three dietary patterns examined, the Mediterranean diet appears most protective for iron status in obese individuals. The ketogenic diet may pose the highest risk due to restricted dietary iron diversity and potential hepcidin-independent absorption impairment. Direct comparative randomized controlled trials are urgently needed. Clinicians should routinely monitor iron biomarkers, including hepcidin, in obese patients undertaking any dietary intervention. Quantitative biomarker data from the 38 included studies showed serum ferritin reductions of 8–28%, hemoglobin levels remaining within clinically stable ranges, and IL-6 decreases of 15–42% across dietary patterns. Full article

Background/Objectives: Gastric cancer (GC) remains a major global health challenge, highlighting the need for safe and effective bioactive compounds for prevention and treatment. Although 10-hydroxy-2-decenoic acid (10-HDA)—a distinctive bioactive fatty component of royal jelly—has demonstrated anticancer activity in several malignancies, its efficacy and underlying mechanisms in GC remain poorly understood. In the present study, the anticancer activity of 10-HDA was systematically investigated in human GC MKN-45 cells. Methods: MKN-45 cells were treated with 10-HDA across a concentration range of 0.09–1.50 mM. Cell viability, proliferation, and clonogenic growth were evaluated using MTT, scratch wound assay, and colony formation assays. Apoptosis was analyzed by flow cytometry and Western blotting. To explore the underlying molecular mechanisms, transcriptome analysis was conducted, and the results were further validated using flow cytometry, qRT-PCR, and Western blotting. Results: Treatment with 10-HDA significantly inhibited cell viability, proliferation, and clonogenic growth in a dose- and time-dependent manner, with IC₅₀ values of 1.24 ± 0.15 mM, 0.96 ± 0.08 mM, and 0.42 ± 0.06 mM at 24 h, 48 h, and 72 h, respectively. Flow cytometric analysis revealed that apoptosis was markedly induced, with the apoptotic rate increasing from 21.3% in control cells to 78.1% following treatment with 1.50 mM 10-HDA. This was accompanied by upregulation of BAX, downregulation of Bcl-2, and increased activation of caspase-3. Transcriptomic profiling identified significant alterations in DNA replication- and cell cycle-related pathways. Consistently, experimental validation demonstrated that 10-HDA induced pronounced G0/G1-phase cell cycle arrest; downregulation of CDK2 and cyclin D1; reduced retinoblastoma protein phosphorylation; and upregulation of the cyclin-dependent kinase inhibitor CDKN1A. Conclusions: These findings demonstrate that 10-HDA suppresses the malignant phenotype of gastric cancer cells by coordinated activation of apoptosis and cell cycle blockade. Although further in vivo studies and pharmacological experiments are required to evaluate its bioavailability and therapeutic potential, this study provides preliminary mechanistic insights into the effects of 10-HDA on gastric cancer cells. Full article

Obesity is a heterogeneous chronic disease for which safe, scalable adjuncts to lifestyle and clinical care remain needed. Tea derived from Camellia sinensis contains catechins, caffeine, theaflavins, thearubigins, theabrownins, polysaccharides, and other constituents whose abundance is shaped by withering, fixation, partial oxidation, full oxidation, and post-fermentation. This review integrates processing-dependent composition with molecular mechanisms, gut–liver signaling, human evidence, safety, and real-world preparation. Evidence is strongest for modest effects of green-tea catechin–caffeine preparations on energy metabolism and selected anthropometric or lipid outcomes, whereas inhibition of adipogenesis, activation of AMP-activated protein kinase, browning of white adipose tissue, and many appetite-related pathways remain supported mainly by cell and rodent studies. A recent meta-analysis in women with overweight or obesity estimated mean reductions of −1.23 kg in body weight and −3.46 cm in waist circumference, with intervention durations across the included trials typically ranging from 4 to 24 weeks, though most of the evidence derives from short- to medium-term interventions (generally ≤12 weeks); heterogeneity was moderate to high and the average weight effect remained below conventional clinical thresholds. Partially oxidized oolong tea and fully oxidized or post-fermented teas provide distinct profiles of caffeine, oxidized polyphenols, and microbial metabolites; their metabolic effects are promising but are less consistently tested in adequately powered human trials. Across tea types, convergent mechanisms include reduced digestive-enzyme activity, increased fatty-acid oxidation, modulation of thermogenesis, reinforcement of the intestinal barrier, and microbiota-dependent production of short-chain fatty acids and bile-acid signals. Translation is constrained by low systemic polyphenol exposure (i.e., limited bioavailability of intact catechins and their metabolites in circulation due to poor intestinal absorption, extensive phase-II metabolism, and rapid clearance), non-standardized doses and products, short intervention periods, interindividual variability, and limited direct comparisons among tea types. Available clinical data do not support tea as a primary treatment for obesity; rather, unsweetened tea or standardized preparations may serve as adjuncts to evidence-based dietary, physical activity, behavioral, and medical management. Priority areas include physiologically relevant dosing, standardized reporting of brewed-tea composition, long-term trials, and microbiome-informed personalization. Full article

Lonicera japonica Thunb. (honeysuckle), a traditional herb with “food-medicine homology” status in Chinese medicine, is valued for its antipyretic and detoxifying properties. This review systematically summarizes its chemical composition—over 507 identified compounds, including phenylpropanoids, flavonoids, triterpenoids, saponins, and the plant-specific miR2911—as well as its multi-target pharmacological mechanisms and emerging translational applications, with particular emphasis on the gut–brain axis-mediated neuroprotective effects. Despite low oral bioavailability, honeysuckle polysaccharides and chlorogenic acid have been shown to exert significant neuroprotection in Alzheimer’s disease models by modulating gut microbiota composition, increasing short-chain fatty acid production, and restoring intestinal barrier integrity—a mechanism that challenges conventional direct-action paradigms. We also outline the applications of honeysuckle in functional foods, pharmaceuticals, animal husbandry, and cosmetics, and propose future directions including precision fermentation and mechanism-driven clinical trials. By integrating phytochemistry, pharmacology, and biotechnology, this review provides a roadmap for the evidence-based development of honeysuckle as a precise medicinal and edible resource. Full article

Krill oil (KO) is a marine-derived nutritional ingredient distinguished by its unique structural composition and increasing relevance in human nutrition, particularly in the context of healthy aging and preservation of intrinsic capacity. Approximately 30–65% of its fatty acids are esterified to phospholipids, a molecular configuration associated with enhanced bioavailability and efficient tissue incorporation of omega-3 polyunsaturated fatty acids, even at relatively low doses. Antarctic krill (Euphausia superba) originates from minimally impacted marine ecosystems, contributing to a favorable safety profile characterized by inherently low levels of environmental contaminants, including heavy metals and persistent organic pollutants. Beyond its structural and safety attributes, KO provides a complex nutrient matrix comprising approximately 25% total n-3 polyunsaturated fatty acids (PUFAs), including ~14% eicosapentaenoic acid (EPA) and ~6.5% docosahexaenoic acid (DHA), together with choline and astaxanthin. This compositional synergy may modulate inflammatory pathways, redox balance, membrane dynamics, and cellular signaling, thereby influencing physiological systems implicated in aging biology. This narrative review critically examines how these distinctive characteristics translate into clinically relevant outcomes supporting the multifunctional applications of KO in human nutrition. The analysis is structured within the framework of intrinsic capacity, encompassing locomotion, vitality, sensory, cognition and psychological dimensions, as a conceptual model for healthy aging. Considerations on bioavailability, tolerability, and sustainability are also discussed in the context of nutritional strategies promoting healthy longevity. Full article

Resveratrol is a plant-derived stilbene polyphenol that has attracted interest as a potential dietary additive for improving edible fish muscle quality. This review summarizes current evidence on pre-harvest dietary resveratrol supplementation and its possible effects on nutritional composition, flavor-related biochemical traits, and physicochemical quality of fish muscle or fillets. We distinguish nutritional quality, including proximate composition, amino-acid profiles, and fatty-acid composition, from flavor-related and sensory-relevant proxies, such as free amino acids, inosine monophosphate, volatile precursors, color, pH, water-holding capacity, and texture. Direct evidence from edible fish muscle remains limited and fragmented, and most available studies rely on biochemical or instrumental endpoints rather than trained-panel sensory evaluation or consumer acceptance testing. Reported effects suggest species- and dose-dependent changes in muscle protein deposition, amino-acid accumulation, fatty-acid composition, pH, cooking or drip loss, and texture-related traits. Putative mechanisms may involve antioxidant protection, muscle fiber remodeling, lipid metabolism, endoplasmic-reticulum stress, and delivery-dependent bioavailability; however, many mechanistic links are still inferred from hepatic tissues, mammalian models, or in vitro systems. Future studies should combine standardized dose–response feeding trials with gas chromatography–mass spectrometry (GC–MS)-based volatile profiling, lipid and protein oxidation indices, instrumental texture analysis, sensory evaluation, and shelf-life testing before resveratrol can be recommended as a robust feed-based strategy for improving edible fish muscle quality. Full article

Background: The global shift to sustainable diets has raised interest in plant-based protein sources, particularly pulses, due to their nutritional value, health benefits, and low environmental impact. Pulses are rich in protein, dietary fiber, and a variety of bioactive compounds that may influence gut microbiota and metabolic health. Objective: This narrative review aims to evaluate the role of pulse consumption in modulating gut microbiota, improving metabolic health, and contributing to the prevention of non-communicable diseases (NCDs), while considering the impact of processing techniques such as fermentation and sustainability aspects. Methods: A comprehensive literature search was conducted using major scientific databases to identify relevant studies published during the last 10 years. Evidence from in vitro, in vivo experimental and human studies was included, focusing on pulse composition, bioactive compounds, gut microbiota modulation, metabolic outcomes, and the effects of processing methods such as fermentation. Results: Pulses demonstrate promising potential to improve gut health by promoting beneficial microbiota, increasing short-chain fatty acid production, and enhancing intestinal barrier function. Evidence also suggests favorable effects on lipid metabolism, glycemic control, and inflammation. Processing techniques, particularly fermentation, improve nutrient bioavailability, digestibility, and bioactive profiles. Beyond health outcomes, this review places pulses in the larger context, emphasizing their contribution to healthy, sustainable diets. Conclusions: Pulses are key components for achieving sustainable, health-promoting diets with promising effects on gut and metabolic health. However, current evidence is largely derived from preclinical studies, highlighting the need for long-term human interventions and scalable processing strategies to fully realize their potential. Full article

This review examines the structural variety, distribution, and physicochemical properties of chlorogenic acids (CGAs), identifying coffee and green coffee as the leading dietary sources of these compounds. Preclinical studies indicate that plant-derived phenolic compounds exhibit strong antioxidant, anti-inflammatory, neuroprotective, cardioprotective, and antidiabetic effects across various disease models. The biological effectiveness of CGAs is attributed to their modulation of cellular signaling pathways, particularly by activating the erythroid 2-related factor 2 antioxidant defense mechanism and inhibiting the pro-inflammatory nuclear factor kappa B pathway. The regulation of the energy-sensing Sirtuin 1 and AMP-activated protein kinase pathways further enhances these therapeutic effects. In the gastrointestinal tract, CGAs serve as key modulators of the microbiota–gut–brain axis by exerting prebiotic-like effects, lowering the Firmicutes/Bacteroidetes ratio, promoting the production of short-chain fatty acids, and preserving gut barrier integrity. Some preclinical studies with coffee, Ilex paraguariensis, Eugenia uniflora, and other CGAs-rich extracts are also discussed. However, despite strong preclinical evidence, translating these findings into human clinical settings remains inconsistent due to significant individual differences in gut microbiota metabolism and the confounding effects of other components in dietary supplements, such as caffeine. Considering this, the review will first explore the molecular mechanisms supporting the potential development of CGAs as preventive interventions, while also discussing current human trials demonstrating selective improvements in neurological, cardiovascular, and metabolic functions. It will also highlight a historical limitation: the lack of studies on the bioavailability, bioactivity, and efficacy of isolated CGAs. The review will conclude by addressing the constraints of clinical studies, emphasizing the urgent need for future precision nutrition frameworks that employ standardized CGAs formulations to enhance potential therapeutic outcomes. Full article

Omega-3 polyunsaturated fatty acids (ω-3 PUFAs), specifically eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are critical modulators of cardiovascular physiology, acting through anti-inflammatory signaling, membrane remodeling, and transcriptional regulation. Despite strong biological plausibility, clinical evidence remains heterogeneous. This narrative review evaluates the complexities of ω-3 supplementation, moving beyond standardized dosing to discuss the emerging role of biomarker-based assessments. While traditional low-dose mixed formulations often failed to show significant benefits, high-dose purified EPA (icosapent ethyl, 4 g/day) has demonstrated a substantial reduction in residual cardiovascular risk in specific populations. However, this clinical success is accompanied by a modest but consistent increase in atrial fibrillation risk at pharmacological doses, suggesting a need for better risk stratification. We highlight that therapeutic efficacy is closely tied to bioavailability—driven by chemical form and dietary context. In this setting, objective metrics such as the ω-3 Index or EPA/arachidonic acid (AA) ratio are discussed as validated biomarkers of ω-3 status that, although not yet incorporated into clinical guidelines as routine treatment targets, may help account for inter-individual variability. Furthermore, we address the environmental burden of marine-derived oils, considering microalgae-based alternatives as sustainable solutions. Ultimately, this review advocates for a more nuanced approach that integrates clinical evidence, the potential of biomarker monitoring, and global environmental responsibility. Full article

Anaerobic digestion (AD) plays a key role in the circular bioeconomy by converting organic waste into renewable energy and facilitating the sustainable utilisation of waste materials. Agricultural and agro-industrial by-products are increasingly recognised as valuable AD feedstocks due to their widespread availability and significant bioenergy potential. However, many of these substrates contain plant-derived bioactive compounds, such as polyphenols, tannins, flavonoids and terpenes, which can influence microbial communities and process performance. Depending on their concentration and chemical characteristics, these compounds may inhibit microbial activity, impair process stability, and ultimately decrease methane production. This review critically synthesises current knowledge on the occurrence, bioavailability and biological activity of plant-derived bioactive compounds in agricultural feedstocks used for anaerobic digestion, with particular emphasis on their implications for process performance and reactor stability. The principal mechanisms through which phytochemicals influence anaerobic digestion include enzyme inhibition, membrane disruption, interference with syntrophic interactions and trace metal chelation. The available evidence demonstrates a pronounced dose-dependent response, whereby low concentrations may exert neutral or selective modulatory effects. In contrast, elevated concentrations disrupt microbial activity, leading to volatile fatty acid accumulation, prolonged lag phases and reduced methane production. Current mitigation strategies include substrate pretreatment, co-digestion, microbial adaptation, adsorbent-assisted detoxification and the use of DIET-promoting materials. An integrated evidence matrix is proposed to link phytochemical composition with reactor configuration, operational parameters and mitigation strategies, thereby providing a practical framework for feedstock-specific process optimisation. Overall, the available evidence demonstrates that reliable evaluation of agricultural feedstocks should extend beyond conventional biochemical methane potential assessment to incorporate phytochemical composition, microbial functional responses and key operational parameters. Such an integrated approach can improve the prediction of methane recovery and support evidence-based optimisation of anaerobic digestion within circular bioeconomy systems. Full article

Background: Phytosterols are natural compounds that provide health benefits by lowering LDL cholesterol levels, but they are susceptible to thermo-oxidative degradation during food storage and processing. Encapsulating them in liposomes could increase their stability and bioavailability. The aim of this study was to examine the stability of phytosterols encapsulated in liposomes during heating of mayonnaise at temperatures simulating storage and frying conditions. Methods: Mayonnaise containing 2, 4, 6, and 8% liposomes encapsulating stigmasterol oleate was prepared and heated at 60 °C for 8 h and at 180 °C for 30, 60, 90, and 120 min. The fat content, percentage composition of fatty acids and levels of oleic acid and stigmasterol were determined in each tested mayonnaise. Results: The fat content of mayonnaise with liposomes heated at 60 °C for 8 h was 97–98%. During heating at 180 °C for 60 min, it reached 100%, and after 120 min, it decreased to 75%. The oleic acid content of liposome-enriched mayonnaise remained stable during heating. The greatest loss of stigmasterol was observed in the control sample without liposomes, in which the sterol content decreased 79%. After heating mayonnaise with liposomes, the decrease in stigmasterol ranged from 3 to 25% at 60 °C for 8 h and from 90% to 100% at 180 °C for 90 and 120 min. Conclusions: Enriching mayonnaise with phytosterol esters encapsulated in liposomes can effectively improve the thermal-oxidative stability of plant sterols during short-term heating, but does not protect the product from the loss of these sterols during prolonged, intense heating. Full article

Neuropathic pain is a chronic, difficult-to-treat condition arising from injury or disease of the somatosensory nervous system. Current pharmacological treatments provide limited relief for many patients and are often associated with adverse effects, highlighting the need for complementary mechanism-based strategies. Neuroinflammation and oxidative stress are pivotal and interdependent drivers of neuropathic pain, promoting glial activation, cytokine release, mitochondrial dysfunction, redox imbalance, ion channel sensitization, and peripheral and central sensitization. Nutraceuticals and dietary bioactive compounds have gained attention because of their pleiotropic actions, i.e., multiple pharmacological activities, on inflammatory, oxidative, metabolic, mitochondrial, and neuroimmune pathways. This review summarizes the mechanistic roles of neuroinflammation and oxidative stress in neuropathic pain and discusses evidence supporting nutraceutical-based interventions, including polyphenols, terpenoids, alkaloids, fatty acids and lipid-derived compounds, antioxidant nutraceuticals, vitamins, and micronutrients. Preclinical studies indicate that these compounds can attenuate pain-related behaviors by modulating redox-sensitive inflammatory signaling, glial reactivity, mitochondrial function, nociceptive ion channels, and endogenous antioxidant defenses. Although clinical evidence remains limited, selected compounds, including alpha-lipoic acid, palmitoylethanolamide, omega-3 fatty acids, B-complex vitamins, vitamin D, and capsaicin, show translational promise. Future studies should prioritize standardized formulations, bioavailability, dosing, safety, mechanistic biomarkers, and robust randomized trials to clarify their clinical role as complementary, multi-target strategies for neuropathic pain management. Full article

Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by Aβ deposition, tau hyperphosphorylation, and neuroinflammation. No effective drugs can slow disease progression. Polysaccharides from traditional Chinese medicine (TCM) exhibit neuroprotective activities (e.g., antioxidant, anti-inflammatory) with good safety. However, their clinical application is limited by low oral bioavailability, poor blood–brain barrier (BBB) permeability, and a pharmacokinetic–pharmacodynamic paradox. The emerging role of the microbiota–gut–brain axis in AD offers a strategy to overcome this paradox. This review summarizes the structural features and classification of TCM polysaccharides (from plants, fungi, and roots/rhizomes) and highlights their anti-AD mechanisms via the gut–brain axis. Acting as prebiotics, these polysaccharides escape upper digestion and are fermented by gut microbiota into short-chain fatty acids (SCFAs) and other metabolites, which enter circulation, cross the BBB, and alleviate AD pathology through metabolic, immune, and neuronal pathways. Outcomes include reduced Aβ deposition and tau phosphorylation, suppressed neuroinflammation, restored synaptic function, and improved cognition. This review provides a theoretical framework for TCM polysaccharide intervention in AD via the gut–brain axis and a pharmacological basis for developing natural product-based AD therapies. Full article